Your session is about to expire
← Back to Search
Creatine monohydrate for Peripheral Arterial Disease
Study Summary
This trial is investigating whether a research device that induces muscle stretching, and creatine loading, impacts submaximal exercise performance in aged and PAD patients.
- Peripheral Arterial Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 14 Patients • NCT01514630Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any deleterious effects from taking Creatine monohydrate?
"Based on its Phase 2 status, Creatine monohydrate's safety has been rated as a 2 - there is evidence to suggest it is safe but none that confirms efficacy."
What is the aggregate number of participants in this clinical trial?
"Confirmatory evidence from clinicaltrials.gov signals that the investigation is actively enlisting volunteers, with recruitment beginning on May 12th 2020 and last updated March 16th 2022. This project requires 40 people between 1 location to take part in its experimentations."
What criteria must individuals meet to qualify for participation in this clinical trial?
"To be considered for this trial, individuals must have peripheral arterial disease and an age between 40-95. Currently, 40 participants are being recruited for the study."
Is enrollment available during this period of the clinical trial?
"Per clinicaltrials.gov, this research is still actively seeking participants after being initially posted on May 12th 2020 and last modified on March 16th 2022."
Are individuals aged 75 and beyond eligible to participate in this trial?
"Individuals who meet the criteria for this clinical trial should be between 40 and 95 years old. Additionally, 11 research projects are available to people younger than 18, while 210 trials cater to seniors over 65."
Share this study with friends
Copy Link
Messenger